Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

Original Article

F.L. Locke, D.B. Miklos, C.A. Jacobson, M.-A. Perales, M.-J. Kersten, O.O. Oluwole, A. Ghobadi, A.P. Rapoport, J. McGuirk, J.M. Pagel, J. Muñoz, U. Farooq, T.v. Meerten, P.M. Reagan, A. Sureda, I.W. Flinn, P. Vandenberghe, K.W. Song, M. Dickinson, M.C. Minnema, P.A. Riedell, L.A. Leslie, S. Chaganti, Y. Yang, S. Filosto, J. Shah, M. Schupp, C. To, P. Cheng, L.I. Gordon, and J.R. Westin

N Engl J Med 2022;386:640-654

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
02/16/2022
Course expires: 
02/17/2024

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Course closed

This course closed on Saturday, February 17, 2024 - 11:59pm.